Please use this identifier to cite or link to this item: http://ir.swu.ac.th/jspui/handle/123456789/11932
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPavarajarn W.
dc.contributor.authorPavarajarn W.
dc.contributor.authorRungsiwiwut R.
dc.contributor.authorNumchaisrika P.
dc.contributor.authorVirutamasen P.
dc.contributor.authorPruksananonda K.
dc.date.accessioned2021-04-05T03:01:29Z-
dc.date.available2021-04-05T03:01:29Z-
dc.date.issued2020
dc.identifier.issn10313613
dc.identifier.other2-s2.0-85085759402
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85085759402&doi=10.1071%2fRD19128&partnerID=40&md5=b25edf19d03839bf4bf85b20c8ef0aaf
dc.identifier.urihttp://ir.swu.ac.th/jspui/handle/123456789/11932-
dc.description.abstractIn a feeder-dependent culture system of human pluripotent stem cells (hPSCs), coculture with mouse embryonic fibroblasts may limit the clinical use of hPSCs. The aim of this study was to determine the feasibility of using human Caesarean scar fibroblasts (HSFs) as feeder cells for the culture of hPSCs. HSFs were isolated and characterised and cocultured with hPSCs, and the pluripotency, differentiation ability and karyotypic stability of hPSCs were determined. Inactivated HSFs expressed genes (including inhibin subunit beta A (INHBA), bone morphogenetic protein 4 (BMP4), fibroblast growth factor 2 (FGF2), transforming growth factor-β1 (TGFB1), collagen alpha-1(I) (COL1A1) and fibronectin-1 (FN1) that have been implicated in the maintenance of hPSC pluripotency. When HSFs were used as feeder cells, the pluripotency and karyotypic stability of hPSC lines did not change after prolonged coculture. Interestingly, exogenous FGF2 could be omitted from the culture medium when HSFs were used as feeder cells for hESCs but not hiPSCs. hESCs cocultured with HSF feeder cells in medium without FGF2 supplementation maintained their pluripotency (as confirmed by the expression of pluripotency markers and genes), differentiated in vitro into embryonic germ layers and maintained their normal karyotype. The present study demonstrates that HSFs are a novel feeder cell type for culturing hPSCs and that supplementation of exogenous FGF2 is not necessary for the Chula2.hES line. © 2020 CSIRO.
dc.subjectbone morphogenetic protein 4
dc.subjectcollagen type 1
dc.subjectfibroblast growth factor 2
dc.subjectfibronectin
dc.subjectinhibin A
dc.subjecttransforming growth factor beta1
dc.subjectanimal cell
dc.subjectArticle
dc.subjectcell differentiation
dc.subjectcell isolation
dc.subjectcesarean section
dc.subjectcoculture
dc.subjectcontrolled study
dc.subjectembryo
dc.subjectembryonic germ cell
dc.subjectfeasibility study
dc.subjectfeeder cell
dc.subjectfibroblast
dc.subjectgene expression
dc.subjecthuman
dc.subjecthuman cell
dc.subjectkaryotype
dc.subjectmouse
dc.subjectnonhuman
dc.subjectpluripotent stem cell
dc.subjectscar
dc.subjectstem cell culture
dc.titleHuman Caesarean scar-derived feeder cells: A novel feeder cell type for culturing human pluripotent stem cells without exogenous basic fibroblast growth factor supplementation
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationReproduction, Fertility and Development. Vol 32, No.9 (2020), p.822-834
dc.identifier.doi10.1071/RD19128
Appears in Collections:SCOPUS 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.